Health officials on Thursday said they are optimistic about a relatively new HIV antiviral medication called lenacapavir that ...

Lenacapavir has the potential to end the HIV epidemic, researchers say. The Trump administration says backing this kind of ...

However, in Dallas County, we found an opportunity where we could apply our AI-driven modeling to solve a difficult situation ...

The U.S. government is making a pre-market commitment to purchase the drug lenacapavir from Gilead Sciences, an American Company. Lenacapavir is a ...

GENEVA, 5 September 2025 —UNAIDS welcomes the announcement by the US State Department that the President’s Emergency Plan for AIDS Relief (PEPFAR) will be supporting an initiative by the Global Fund ...

UNAIDS welcomes the announcement by the US State Department that the President's Emergency Plan for AIDS Relief (PEPFAR) will ...

A Russian HIV vaccine, based on mRNA technology, may be ready within the next two years, according to Vladimir Gushchin, the head of epidemiology at ...

Scientists have decoded the 3D structure of an ancient viral protein hidden in our DNA. The HERV-K Env protein, found on ...

Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.

Precise genome-editing technology to cure HIV PROVIREX is developing first-in-class advanced therapies that may offer the chance of a cure for people with life-threatening persistent viral infections.

Funded through a $17 million NIH grant, the program will try six strategies to combat HIV and advance the most promising.